Literature DB >> 12649172

Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.

Kolja Freier1, Stefan Joos, Christa Flechtenmacher, Frauke Devens, Axel Benner, Franz X Bosch, Peter Lichter, Christof Hofele.   

Abstract

Fluorescence in situ hybridization was applied on a collection of 609 squamous cell carcinomas of the head and neck (HNSCCs),including 511 primary carcinomas of different clinical stage and anatomical localization and 98 recurrent carcinomas, second primary carcinomas, and regional metastases on a tissue microarray. The overall prevalence of amplifications of five oncogenes analyzed was 34.5% for CCND1, 12.7% for EGFR, 8.8% for MYC, 6.2% for ZNF217, and 3.6% for ERBB2. CCND1 amplifications were associated with the pharyngeal site in primary carcinomas (P < 0.001), whereas amplifications of ZNF217 were less frequent in pharyngeal carcinomas as compared with primary oral and laryngeal carcinomas (P = 0.02). The amplification pattern of these oncogenes suggests that different molecular pathways are involved in HNSCCs of different localizations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649172

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  Her-2 immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, not Her-2 amplification.

Authors:  Dimitrios Papavasileiou; Konstantinos Tosios; Panos Christopoulos; Nikolaos Goutas; Dimitrios Vlachodimitropoulos
Journal:  Head Neck Pathol       Date:  2009-08-22

Review 2.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

3.  Increased C-MYC copy numbers on the background of CDKN2A loss is associated with improved survival in nodular melanoma.

Authors:  Denitsa Koynova; Ekaterina Jordanova; Nicole Kukutsch; Pieter van der Velden; Draga Toncheva; Nelleke Gruis
Journal:  J Cancer Res Clin Oncol       Date:  2006-09-15       Impact factor: 4.553

Review 4.  Are histochemistry and cytochemistry 'Omics'?

Authors:  Gary Coulton
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

5.  Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.

Authors:  Stephan Mathas; Stephan Kreher; Karen J Meaburn; Korinna Jöhrens; Björn Lamprecht; Chalid Assaf; Wolfram Sterry; Marshall E Kadin; Masanori Daibata; Stefan Joos; Michael Hummel; Harald Stein; Martin Janz; Ioannis Anagnostopoulos; Evelin Schrock; Tom Misteli; Bernd Dörken
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-25       Impact factor: 11.205

6.  An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas.

Authors:  Yusuke Zushi; Mako Narisawa-Saito; Kazuma Noguchi; Yuki Yoshimatsu; Takashi Yugawa; Nagayasu Egawa; Masatoshi Fujita; Masahiro Urade; Tohru Kiyono
Journal:  Am J Cancer Res       Date:  2011-08-18       Impact factor: 6.166

7.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

8.  Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue.

Authors:  Cory L Grand; Tiffanie J Powell; Raymond B Nagle; David J Bearss; Denise Tye; Mary Gleason-Guzman; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

9.  The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.

Authors:  W J Pattje; E Schuuring; M F Mastik; L Slagter-Menkema; M L Schrijvers; S Alessi; B F A M van der Laan; J L N Roodenburg; J A Langendijk; J E van der Wal
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

10.  Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Authors:  L Licitra; R Mesia; F Rivera; É Remenár; R Hitt; J Erfán; S Rottey; A Kawecki; D Zabolotnyy; M Benasso; S Störkel; S Senger; C Stroh; J B Vermorken
Journal:  Ann Oncol       Date:  2010-11-03       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.